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Variants in PAX6, PITX3 and HSF4 causing autosomal dominant
congenital cataracts
Vanita Berry 1,2✉, Alex Ionides2, Nikolas Pontikos 1,2, Anthony T. Moore2, Roy A. Quinlan3 and Michel Michaelides 1,2✉
© Crown 2021
BACKGROUND: Lens development is orchestrated by transcription factors. Disease-causing variants in transcription factors and
their developmental target genes are associated with congenital cataracts and other eye anomalies.
METHODS: Using whole exome sequencing, we identified disease-causing variants in two large British families and one isolated
case with autosomal dominant congenital cataract. Bioinformatics analysis confirmed these disease-causing mutations as rare or
novel variants, with a moderate to damaging pathogenicity score, with testing for segregation within the families using direct
Sanger sequencing.
RESULTS: Family A had a missense variant (c.184 G>A; p.V62M) in PAX6 and affected individuals presented with nuclear cataract.
Family B had a frameshift variant (c.470–477dup; p.A160R*) in PITX3 that was also associated with nuclear cataract. A recurrent
missense variant in HSF4 (c.341 T>C; p.L114P) was associated with congenital cataract in a single isolated case.
CONCLUSIONS: We have therefore identified novel variants in PAX6 and PITX3 that cause autosomal dominant congenital cataract.
Eye; https://doi.org/10.1038/s41433-021-01711-x
INTRODUCTION
Cataract the opacification of the eye lens is the most common, but
treatable cause of blindness in the world (https://www.who.int/
publications-detail/world-report-on-vision). Congenital cataracts
are detected at birth or during the first decade of life. Hereditary
cataract can be isolated or be a part of other ocular defects like
anterior segment mesenchymal dysgenesis, glaucoma, microcor-
nea, or aniridia; and systemic disorders such as heart disease,
diabetes, deafness and Wolframin disease [1, 2]. Congenital
cataract is usually autosomal dominant, followed by autosomal
recessive and X linked inheritances. Congenital cataract are
clinically and genetically heterogeneous, displaying various
phenotypes [3].
So far nearly 50 genes have been found causing mostly isolated
congenital cataracts broadly including genes encoding lens
soluble proteins –crystallins; membrane proteins- gap junctions,
aquaporins, receptor tyrosine kinase gene EPH receptor A2, an
endoplasmic reticulum membrane-embedded protein, Wolframin,
chromatin modifying protein-4B, lens integral membrane protein;
AQP0, Connexin 50 and LIM2 cytoskeletal proteins- filensin,
phakinin, vimentin and genes encoding transcription or develop-
mental factors EYA1, MAF, FOXE3, VSX2, PAX6, PITX3 and HSF4
(https://cat-map.wustl.edu/) [4–6].
Transcription factors and developmental genes play a key role
spatio-temporally in the embryonic development of ocular and
other embryonic tissues [7, 8]. Disease-causing variants in these
genes can be devastating for the developing eye, even causing
anophthalmia [9, 10]. They display a spectrum of eye anomalies in
the anterior segment of eye, but nuclear cataract phenotypes are
consistent with early developmental effects as would be
anticipated for PAX6 and PITX3 transcription factors. Recently,
we have found two novel mutations in the transcription factors
PAX6, PITX3 and one recurrent variant in HSF4.
PAX6, a paired-box and homeobox domain gene is one of the
principal regulators in eye development, first described as a
candidate for human aniridia [11]. PAX6 plays an important role in
the early development of the lens including the interaction
between the embryonic surface ectoderm and the budding optic
vesicle. This interaction is critical for normal lens induction [12–14].
PAX6 is also expressed in the central nervous system, olfactory
system and pancreas [15–17]. PAX6, a transcriptional regulator
gene on chromosome 11p13, consists of 14 exons spanning 22 kb
genomic region, encodes 422 amino acid residues. PAX6 consists
of two highly conserved DNA-binding domains: at N-terminus a
paired domain (PD) with N-terminal (NTS) and C-terminal (CTS)
subdomains and the middle homeodomain (HD) connected by 79-
amino-acid linker region. The C-terminal end of protein is a
transregulatory region enriched in proline, serine and threonine
called the PST domain [18, 19]. The human PAX6 gene produces
two alternative splice isoforms due to the insertion of 14
additional amino acids encoded by exon 5a into the NTS
subdomain of PD, which abolishes the DNA-binding activity of
the NTS and unmasks the DNA-binding ability of the CTS
subdomain [20]. Pathogenic variants in PAX6 cause severe
lenticular and non-lenticular defects.
PITX3 a paired-like homeodomain transcription factor gene is a
member of the REIG/PITX family of homeobox transcription
factors, including PITX1 and PITX2 [21]. PITX2 and PITX3
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participate in eye development and express in most developing
ocular tissues, including the retina, lens and cornea [22]. Mutations
in PITX2 have been linked to Rieger syndrome causing glaucoma
and mild craniofacial dysmorphism in humans [23]. In the aphakia
mouse mutant, two deletions in the promoter of the homeobox
transcription factor Pitx3 lead to loss of its function and to arrest of
eye development at the lens stalk stage [24].
HSF4 belongs to the heat-shock transcription factors family
that regulate the expression of heat-shock proteins in response
to various stresses, such as high temperature, infection, and free
radicals, and also in development. In the lens HSF4 is expressed
in both cell types (epithelial cells and fibre cells) at an early
stage of development and is required for normal cell growth
and differentiation of these two cell types [25] and for
transcription regulation of αB-crystallin in the lens [26]. Disease
causing variants in HSF4 cause both dominant and recessive
cataracts.
Herein we report two novel and one known variant(s) in PAX6,
PITX3 and HSF4 genes.
METHODS
Phenotyping
Patients were identified via the proband attending the Genetic Service at
Moorfields Eye Hospital, London, UK. The study protocol adhered to the
Tenets of the Declaration of Helsinki and was approved by UCL research
ethics committee, (project ID − 4817/001). All the family members
participating in this study gave written informed consent and underwent
full ophthalmic examination, including slit lamp examination. All affected
individuals from two families and one isolated case were diagnosed as
having an isolated congenital cataract as described below.
Whole exome sequencing (WES) and bioinformatics analysis
Genomic DNA was extracted from EDTA treated blood samples using the
Nucleon II DNA Extraction Kit (Scotlab Bioscience, Strathclyde, Scotland,
UK). The DNA samples were sequenced at Macrogen Europe. Exon capture
and target enrichment was performed using the SureSelectXT Human All
Exon V6 post, (Agilent, Santa Rosa, CA, USA). Paired-end sequencing was
performed on an Illumina Hiseq 2500 high-throughput sequencer,
generating mean exome coverage of 50x. Raw data in fastq format was
aligned to the UCSC Genome Browser GRCh37/hg19 human reference
sequence and analysed using the Phenopolis bioinformatics platform as
before [27, 28]. We used tiered approach to prioritised rare coding variants
using Kaviar (http://db.systemsbiology.net/kaviar/) [29] and Genome
Aggregation Database (GnomAD http://gnomad.broadinstitute.org/) or
rare variants (GnomAD allele frequency <0.0001) in all the known cataract
genes (https://cat-map.wustl.edu/). The variant were then filtered using
CADD score, predicted to be moderately or highly damaging (CADD>15)
with the highest at the top for both known and unknown genes for
cataracts. Further bioinformatic validations were done on the varsome
platform (varsome.com).
Sanger sequencing
Sanger sequencing was performed to validate the variant identified by
whole exome sequencing. Genomic DNA was amplified by PCR using
GoTaq 2X master mix (AB gene; Thermo Scientific, Epsom, UK) and PAX6,
PITX3 and HSF4 -specific primers designed with http://bioinfo.ut.ee/
primer3-0.4.0/ PCR conditions were as follows: 94 °C for 5 min of initial
denaturation followed by 30 cycles of amplification of 30 s at 94 °C
denaturing, 30 s at 60 °C annealing, and 45 s at 72 °C for extending. After
cleaning, the PCR products were reacted with BigDye Terminator v3.1, they
were run on ABI 3730 Genetic Analyzer (both from Applied Biosystems,
Foster City, CA, USA) and analysed using SeqMan Pro (version 8.0.2 from
DNASTAR) sequence analysis. After validating the variant, segregation was
performed in all the available family members.
The protein structure of PAX6 and HSF4 were analysed using







In this study, we have investigated two families A and B and an
isolated individual C with autosomal dominant congenital
cataract.
Family A- novel missense variant (c.184 G>A; p.V62M) in PAX6
A four-generation pedigree of 22 individuals with four spouses,
nine unaffected and nine affected presenting with nuclear
cataract (Fig. 1a - Fam A). Individual II-7 had bilateral congenital
cataract and nystagmus, Individual IV-1 had bilateral congenital
cataract and surgery was performed at age 1. This individual also
had congenital nystagmus. One affected individual (IV-1) was
sequenced by WES. After the Phenopolis genetic variant analysis
pipeline, variants were filtered by allele frequency and from a total
of 3204 rare coding variants, 381 variants remained. The top
scoring variant for CADD was a rare heterozygous variant
NM_001258462.3: c.184 G>A; p.V62M in exon 7 of PAX6 with a
score of 27.6. Direct Sanger sequencing confirmed the variant
(Fig. 1b), which co-segregated in the affected family members.
Family B- novel frameshift variant (c.470–477dup; p.A160R*)
in PITX3 with nuclear cataract
A three-generation family with nuclear cataract comprising seven
members, including three affected, two unaffected, and two
spouses, were examined (Fig. 1a- Fam B). Affected individuals had
bilateral cataract and surgery was performed in infancy. One
affected individual (II-3) was sequenced by WES. Variant annota-
tion and tiered filtering yielded 512/3164 variants and further a
rare heterozygous variant NM_001040667.3: c.470_477dup
(CTTGGGCG-8bp dup); p.Ala160ArgfsTer152 in exon 4 of PITX3,
with a highest CADD score of 34 was found. Sanger sequencing
confirmed the variant (Fig. 1c), and it co-segregated in the
affected individuals.
An individual C, with congenital cataract underwent WES.
Following, variant analysis and filtering, one rare variant remained
with a top CADD score of 31. This variant happened to be a
recurrent variant NM_001040667.3 c.341 T>C; p.L114P in exon 5 of
HSF4, validated by Sanger sequencing (Fig. 1d). Pathogenicity
scores for all the three variants are shown in Table 1.
Swiss modelling
The protein structure of PAX6 and HSF4 were analysed using










Transcription factor genes like PAX6 [30–32] PITX3 [33, 34] and
HSF4 [26, 35] are critically important for eye development.
Disease-causing variants in these cause severe ocular defects
and congenital cataracts that may be part of non-lenticular
diseases.
HSF4 expression is tissue specific and it has two splice forms
HSF4a & HSF4b. HSF4 gene resides on chromosome 16q22.1,
comprised of 15 exons and encodes a heat-shock transcriptional
protein of 493 amino-acid residues with a DNA binding domain
(DBD), an amino-terminal hydrophobic repeat (HR/A-B), an
isoform-specific region and downstream of hydrophobic repeat
(DHR) [36, 37]. Mutations in this gene cause both autosomal





























Fig. 1 Pedigrees and sequence analysis. a Family A: Abridged pedigree with nuclear cataract; Family B: Abridged pedigree with nuclear
cataract. The diagonal line indicates a deceased family member. Squares and circles symbolise males and females, respectively. Open and
filled symbols indicate unaffected and affected individuals, respectively. Diamond symbolises-number of unaffected siblings grouped
together. The arrow indicates the family members who participated in the WES analysis. All the available members in the family were
sequenced to show the segregation. b Sequence analysis of (a): PAX6–missense variant c.184 G>A in affected member of family A with nuclear
cataract; (c) PITX3-a frameshift variant at c.470–477dup in an affected member of family B with nuclear cataract; (d) HSF4- missense variant
c.341 T>C in an affected individual with congenital cataract.
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dominant and recessive cataracts, with higher incidence of
dominant suggesting that mutations in the dna binding domain
are dominant negative rather than loss of function. Apparently, all
autosomal-dominant mutations in HSF4 lie within the α-helical
DBD, whereas the recessive variants lie outside this highly
conserved functional domain [38]. HSF4 has been shown to
regulate lens fibre cell differentiation by modulating the expres-
sion of certain lens structural proteins, such as lens specific
crystallins, beaded filament proteins, and fibroblast growth
factors26 and play important role in the de-nucleation of lens
fibre cells [39]. To date 25/27 unique pathogenic variants have
been reported mostly in the Asian population (https://cat-map.
wustl.edu/). Two heterozygous variants at p.L114P and R119C,
both have been reported twice in Chinese [40] and Danish families
[41]. The variant p.L114P has previously been described causing
autosomal dominant lamellar cataract in a Chinese family and AD
lamellar and sutural opacities in a Danish family suggesting further
heterogeneity of the same variant in different ethnic groups
perhaps due to other interacting proteins. Here we report a
recurrent missense variant NM_001040667.3: c.341 T>C; L114P in
the DBD region of the HSF4 protein in an isolated case of English
origin with autosomal dominant bilateral congenital cataract.
PAX6 homozygous variants typically give rise to aniridia or
anophthalmia; but missense variants (nearly 12%) may result in
milder phenotypes including isolated foveal hypoplasia, Peter’s
anomaly, partial aniridia, optic nerve defect and bilateral cataract
[42, 43]. To date, nearly 500 mutations have been reported in
Human PAX6 database (http://lsdb.hgu.mrc.ac.uk/home.php?
select_db=PAX6) displaying (>80%) of heterozygous null mutation
[44]. Most of the missense variants have been found in the PD
region, except one affecting only the C-terminal PST domain,
associated with lamellar cataracts and later-onset corneal dystrophy
[45]. In the lens, PAX6 plays a key role in the regulation of lens-
specific crystallins [46, 47] and over-expression of the PAX6 (5a)
isoform dramatically alters lens fibre cell shape and organisation in
the lenses of transgenic mice [48]. It is a key transcription factor in
lens development as it regulates the expression of crystallins and
other structural proteins in the lens [49]. A list of PAX6 disease
causing variants are shown in Table 2 causing milder ocular
phenotypes and congenital cataract [50–55]. We have identified a
novel missense pathogenic variant in exon 6 (c.184 G>A; p.V62M)
encompassing the paired domain region of PAX6 gene, causing
nuclear cataract.
PITX3 gene comprises of four exons and encodes a protein of 303
amino acid residues located at chromosome 10q25. To date, 28
variants have been identified mostly with an autosomal dominant
inheritance. Two homozygous variants have been observed in
recessive families with severe ocular abnormalities; one at c.650delG;
p.G217AfsX91 causing microphthalmia and central nervous system
defects [56] and second at p.A214RfsX42 causing severe micro-
phthalmia, anterior segment dysgenesis and sclerocornea [57].
Heterozygous 650delG variant has been reported with only
progressive posterior polar cataract in autosomal dominant families
[58]. Half of the PITX3 variants, are represented by a single hot spot
in exon 4 at c.640_656dup17bp; p.G220PfsX95 in the c-terminal
region of the gene that causes mainly AD posterior polar cataracts
and anterior segment dysgenesis in several families around the
globe [58–64] (Fig. 3). The PITX3 variants, a recurrent 17-bp
duplication at c.640_656dup17bp, the p.G220PfsX95 and lastly a 1-
bp deletion at c.573delC; p.S192AfsX117 have been shown to
reduce PITX3 DNA-binding and transactivation activity due to
altered protein length [34, 64]. In a mouse model removal of the C-
terminal domain which contains the highly conserved otp, aristaless,
and rax (OAR) domain leads to micro-ophthalmia and aphakia in
mice [65].
So far, only one PITX3 missense variant p.S13N has been reported
twice causing total cataract in one isolated case [21] and Peter’s
anomaly in another [62]. Interestingly nearly all the frameshift
variants truncate the protein in the COOH region display mostly
isolated posterior polar cataract phenotypes and other ocular
defects (Fig. 3). Here we report a novel frameshift variant at
c.470_477dup (CTTGGGCG-8bp dup); p. Ala160ArgfsTer152 in exon
4 of PITX3 results in a premature termination of the protein at amino
acid residue A160, responsible for an isolated nuclear cataract in an
English Pedigree. This is the first report of nuclear cataract caused by
mutation in PITX3. PITX3 expression is seen in the developing lens,
skeletal muscle, and dopaminergic neurons of the substantia nigra
in the brain and the PITX3 polymorphisms have been shown to be
associated with Parkinson disease [66] dementia [67] and with
neurological abnormalities [68, 69].
CONCLUSIONS
We report two novel and one recurrent cataract-causing variant in
three transcription factor genes important in lens development.
Both the identified novel variants that cause autosomal dominant
cataract provide further evidence of phenotypic heterogeneity.
These variants and their discovery provide further evidence of the
importance of combining clinical characterisation with NGS in
order to understand the biological basis for the phenotypic
variation often associated with familial cataract. The clinical and
genetic heterogeneity now reported in congenital cataract has
begun to rival the vast variability documented in inherited and
isolated eye disease, making ophthalmic genetics the most
heterogeneous in clinical medicine. Our study extends the
mutation spectrum associated with the transcriptional factors
essential to lens development to the benefit of patients through
the improved genetic counselling this knowledge delivers.
Summary
What was known before
● Congenital cataract is clinically and genotypically heteroge-
neous disease. Mutations in transcription factors are known to
cause congenital cataracts and other eye anomalies.
Table 1. Pathogenicity scores for PAX6, PITX3 and HSF4 Variants.
Gene Genomic pos./
Exon
HGVSc HGVSp Phenotype CADD GERP NR MutationTaster/verdict
PAX6 Chr11/Ex7 c.184 G>A p.V62M Nuclear 27.6 5.3 Disease causing/0.81/Pathogenic/Novel
PITX3 Chr10/Ex4 c.470–477dup p.A160R* Nuclear 34 4.46 Disease causing/0.81/Pathogenic/Novel
HSF4 Chr16/Ex5 c.341 T>C p.L114P Congenital
cataract
31 4.86 Disease causing/0.81/Likely pathogenic/
Recurrent
Combined annotation dependent depletion (CADD) is score for the deleteriousness of a variant. A CADD score >20 is considered damaging; genomic
evolutionary rate profiling (GERP) NR corresponds to the neutral rate conservation score of the site.
* designated to truncated protein.
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Fig. 2 Structural view of PAX6 and HSF4 proteins. A Crystal structure of the human PAX-6 paired domain-dna complex reveals a general
model for PAX protein-dna interactions- X-ray diffraction, 2.50 A monomer (4-133 aminoacids). Wt -V62 PAX6: https://swissmodel.expasy.org/
repository/uniprot/P26367 Mut - M62-PAX6: https://swissmodel.expasy.org/interactive/1hpd5p/models/. B Structure of the DNA-binding
domain of HSF2 with sequence homology to HSF4 at aminoacids position (pro18-Val121). Wt: L114 https://swissmodel.expasy.org/interactive/
0QmfH7/models/ Heat shock factor protein 2-Human HSF2 DNA Binding Domain in complex with 3-site HSE DNA at 2.1 Angstroms
Resolution; Mut: P114 https://swissmodel.expasy.org/interactive/Fx4QGZ/models/.
V. Berry et al.
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What this study adds
● We have identified novel heterozygous mutations in PAX6 and
PITX3 in two English families with autosomal-dominant
congenital nuclear cataract.
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